Injectafer denied for missing prior authorization by Humana?

Humana's specific coverage criteria for injectafer are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Injectafer for Prior Authorization

A prior-authorization-required denial means Injectafer (ferric carboxymaltose) was administered or prescribed without an approved prior authorization on file with Humana, or an authorization request was submitted but denied for failure to meet Humana's clinical criteria. PA requirements for IV iron infusions are common among commercial insurers and are not an unusual hurdle — but they must be navigated correctly.

If the drug was given without PA in an urgent or emergent situation, appeal rights specifically address retroactive authorization. If a PA was submitted and denied on clinical grounds, the full appeal process below applies.

## Federal Appeal Framework

ACA §2719 requires external review rights after internal appeal for non-grandfathered plans. ERISA §503 provides full-and-fair review for employer plans, including access to the clinical criteria used in the denial. The external-review window is typically four months from the denial notice. Expedited internal and external review is available when delay would seriously jeopardize health — Humana must respond to expedited internal appeals within 72 hours.

## Concrete Appeal Steps

1. Determine whether this is a retroactive denial (drug already given) or a prospective denial (PA requested but denied before administration). 2. Request Humana's prior-authorization clinical criteria for IV iron replacement in writing. 3. Have your prescriber complete a targeted PA appeal letter addressing each unmet criterion. 4. For retroactive denials in urgent situations, explicitly invoke the urgent-care or emergency exception in your appeal letter. 5. Submit the internal appeal within Humana's deadline (typically 180 days from denial). 6. If denied internally, file for external review within four months.

## Documentation to Gather

• Diagnosis confirmation: Current physician notes and laboratory results confirming the diagnosis and clinical severity.
• Prior-treatment history: Oral iron agents or other alternatives tried, with dates, doses administered, and documented outcomes or reasons for discontinuation.
• Clinical urgency documentation (if applicable): Chart notes explaining why the infusion was needed urgently, if authorization was not obtained in advance.
• Prescriber medical-necessity letter: Directly addresses each of Humana's published PA criteria, referencing the FDA-approved Injectafer prescribing label and the applicable clinical guideline organization.

## Criteria-Mapping Structure

Obtain Humana's published prior-authorization criteria for IV ferric carboxymaltose and the FDA-approved Injectafer prescribing label. Construct a table:

| Humana PA criterion | Corresponding chart documentation | |---|---| | Confirmed diagnosis | [Chart note date + objective evidence] | | Oral iron tried and failed or contraindicated | [Dates, agents, outcomes] | | Prescriber attestation | [PA appeal letter, dated] | | Any plan-specific clinical threshold | [Relevant objective finding from chart] |

For each criterion Humana cited as unmet, the appeal should provide a specific, dated chart entry. PA denials that are appealed with criterion-mapped documentation have a meaningful reversal rate, particularly when a prescriber peer-to-peer is requested alongside the written appeal.